New shot aims to ease depression and anxiety in cancer and chronic illness patients
Symptom relief
Recruiting now
This study tests whether a single injection of RE104 can reduce symptoms of depression or mixed depression and anxiety in people with adjustment disorder caused by a serious illness like cancer, ALS, multiple sclerosis, Parkinson's disease, or idiopathic pulmonary fibrosis. About…
Phase: PHASE2 • Sponsor: Reunion Neuroscience Inc • Aim: Symptom relief
Last updated May 17, 2026 10:26 UTC